This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salát, J.
Right arrow Articles by Kopecky, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salát, J.
Right arrow Articles by Kopecky, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2008, p. 2169-2174, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01506-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Efficacy of Gamma Interferon and Specific Antibody for Treatment of Microsporidiosis Caused by Encephalitozoon cuniculi in SCID Mice{triangledown}

Jirí Salát,* Jirí Jelínek, Jindrich Chmelar, and Jan Kopecky

Biology Centre Academy of Sciences of the Czech Republic, Institute of Parasitology and Faculty of Biological Sciences, University of South Bohemia, Ceské Budejovice, Czech Republic

Received 20 November 2007/ Returned for modification 19 December 2007/ Accepted 11 March 2008

Microsporidia are eukaryotic, obligate, intracellular protists that are emerging pathogens in immunocompromised hosts, including AIDS patients and organ transplant recipients. The efficacy of gamma interferon (IFN-{gamma}) for the treatment of microsporidiosis caused by Encephalitozoon cuniculi was studied by means of adoptive transfer and IFN-{gamma} administration in SCID mice. While the adoptive transfer of CD4+ T cells from immunocompetent mice prolonged survival of SCID mice infected perorally with E. cuniculi, survival was not improved by adoptive transfer of CD4+ T lymphocytes from IFN-{gamma}-deficient mice. The protective effect of IFN-{gamma} was confirmed in cytokine therapy experiments in which SCID mice receiving IFN-{gamma} survived significantly longer than mice receiving mock injections. The administration of serum containing specific antibodies against E. cuniculi was found to prolong the survival of concurrently IFN-{gamma}-treated SCID mice. The data presented in this study suggest that IFN-{gamma} is potentially useful as a cytokine therapy for microsporidiosis, especially in CD4+ T-cell-deficient patients.

* Corresponding author. Mailing address: Jirí Salát, Institute of Parasitology, Biology Centre Academy of Sciences of the Czech Republic, Branisovská 31, 370 05 Ceské Budejovice, Czech Republic. Phone: 420 387 775 458. Fax: 420 385 310 388. E-mail: george{at}paru.cas.cz

{triangledown} Published ahead of print on 17 March 2008.

Antimicrobial Agents and Chemotherapy, June 2008, p. 2169-2174, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01506-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»